Keys to Successful Health Industry Alliances with China

Cypin Production Conference Offers Insights in R&D…and Beyond - March 23, 2012

Cypin Production’s Branded Generics Conference Attracts Unexpected Breadth of Attendees

Some truly ground-breaking topics and dynamic speakers brought attendees from all over the world to the first Branded Generics TM conference held recently in Philadelphia. - March 09, 2012

Business and Operation Excellence for Branded Generics Expansion Into Emerging Markets

Overseas consumers respect and trust branded drugs more than local generics. Consumers perceive the latter as being satisfied with lax quality controls, while branded generics are trusted to have a higher level of quality and effectiveness. Branded generics are likely to reach up to 75 percent of sales growth in emerging markets within the next 10 years. - October 28, 2011

How Does U.S. Pharma Target China Accurately for Expansion? Cypin Production’s Pharma Market Forecasting for China Workshop Offers Advice Like This.

“With a GDP of more than $8 trillion, China is poised to become the world’s third-largest pharmaceutical market by 2013. To successfully meet potential demand and supply for products, accurate forecasting is essential for companies who want to break into China,” says Judy Tsui. - October 12, 2011

Conference to Bring Together Top BioPharma Leaders in U.S. and China

Cypin Production, a newly established leader bringing together experts in biopharmaceuticals in the United States and China, is pleased to announce it will host U.S.-CHINA PHARMA™: Innovative Strategies and Partnership Models for R&D Success. The conference, taking place May 23-24, 2011, at the Hub Cira Centre in Philadelphia, will assemble hundreds of senior pharmaceutical and biotech managers from U.S. and China to discuss best practices in the industry. - March 24, 2011

Cypin Production Announces Launch of U.S./China BioPharma Conference

“Innovative Strategies and Partnership Models for R&D Success.” - November 05, 2010

Newly Established CYPIN PRODUCTION Addresses Win-Win Situation: Building Bridges Between U.S. BioPharma and China

While major developed markets for biopharmaceuticals and life sciences will grow just 3 percent to 6 percent through 2014, emerging markets are expected to grow between 14 percent and 17 percent. One of these especially vital and growing markets in biopharma is China. - October 27, 2010

Press Releases 1 - 7 of 7